GRT-002

N/A

Report date: 2025/07/04 11:37:23
First In Class

Base Information

Drug NameGRT-002
Drug Alias NameGRT-002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionInterleukin-3 inhibitors
TargetsInterleukin-3
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Regensburg
China Registration ClassN/A

Develop Information

Active CompaniesGranite Bio AG
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A